Stockscreener 앱 받기
7.18
7.25%
0.52
4 D Molecular Therapeutics Inc 주식(FDMT)의 최신 뉴스
4D Molecular Therapeutics, Inc. $FDMT Shares Bought by Acadian Asset Management LLC - Defense World
Will 4D Molecular Therapeutics Inc. continue its uptrendJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com
Rate Hike: What hedge funds are buying 4D Molecular Therapeutics Inc2025 Technical Patterns & Accurate Buy Signal Alerts - خودرو بانک
Pullback Watch: How sensitive is 4D Molecular Therapeutics Inc. to inflation2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - خودرو بانک
4D Molecular Therapeutics (NASDAQ:FDMT) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Trend analysis for 4D Molecular Therapeutics Inc. this weekTrade Ideas & AI Powered Market Entry Ideas - newser.com
New Highs: Will 4D Molecular Therapeutics Inc outperform its industry peersJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - خودرو بانک
4D Molecular Therapeutics (NASDAQ:FDMT) Given “Sell (D-)” Rating at Weiss Ratings - Defense World
Levels Update: What is the Moat Score of 4D Molecular Therapeutics IncQuarterly Trade Report & Free Technical Pattern Based Buy Signals - خودرو بانک
Sentiment Recap: Will 4D Molecular Therapeutics Inc benefit from geopolitical trendsJuly 2025 Pullbacks & Smart Allocation Stock Reports - خودرو بانک
Risk Check: Can 4D Molecular Therapeutics Inc sustain its profitabilityWeekly Investment Recap & Accurate Entry/Exit Alerts - خودرو بانک
Cubist Systematic Strategies LLC Sells 364,659 Shares of 4D Molecular Therapeutics, Inc. $FDMT - MarketBeat
What drives Millicom International Cellular SAs stock priceEarnings Recap Report & Fast Exit and Entry Strategy Plans - خودرو بانک
What MACD and RSI say about 4D Molecular Therapeutics Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Applying Wyckoff theory to 4D Molecular Therapeutics Inc. stock2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
How to forecast 4D Molecular Therapeutics Inc. trends using time seriesShort Setup & Real-Time Volume Triggers - newser.com
4DMT Announces New Employment Inducement Grants - GlobeNewswire
Biotech Leader 4DMT Issues 40,900 Restricted Stock Units to Attract Key Non-Executive Talent - Stock Titan
Building trade automation scripts for 4D Molecular Therapeutics Inc.2025 Risk Factors & AI Powered Market Entry Strategies - Newser
How moving averages guide 4D Molecular Therapeutics Inc. tradingWeekly Trade Recap & Free High Return Stock Watch Alerts - Newser
4D Molecular Therapeutics Inc. stock trendline breakdownQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
Should you wait for a breakout in 4D Molecular Therapeutics Inc.Market Weekly Review & Safe Capital Growth Tips - Newser
Visual analytics tools that track 4D Molecular Therapeutics Inc. performancePortfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives $30.40 Average Target Price from Analysts - MarketBeat
Ranking 4D Molecular Therapeutics Inc. among high performing stocks via toolsJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser
Chart based exit strategy for 4D Molecular Therapeutics Inc.Weekly Trend Summary & Risk Managed Investment Strategies - Newser
What indicators show strength in 4D Molecular Therapeutics Inc.Global Markets & Risk Controlled Daily Plans - Newser
Volume spikes in 4D Molecular Therapeutics Inc. stock – what they mean2025 Market Trends & Verified Entry Point Signals - Newser
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer - GlobeNewswire Inc.
Regression analysis insights on 4D Molecular Therapeutics Inc. performanceAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
What candlestick patterns are forming on 4D Molecular Therapeutics Inc.Weekly Profit Report & Growth Focused Entry Reports - Newser
4D Molecular Therapeutics, Inc. $FDMT Shares Bought by Invesco Ltd. - MarketBeat
How to track smart money flows in 4D Molecular Therapeutics Inc.Quarterly Profit Report & Reliable Trade Execution Plans - Newser
Is 4D Molecular Therapeutics Inc. a candidate for recovery playPortfolio Return Report & Step-by-Step Trade Execution Guides - Newser
Is 4D Molecular Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 EndofMonth & Reliable Trade Execution Plans - Newser
Can 4D Molecular Therapeutics Inc. hit a new high this monthJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Nuveen LLC Acquires Shares of 150,314 4D Molecular Therapeutics, Inc. $FDMT - MarketBeat
Detecting support and resistance levels for 4D Molecular Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Picks - Newser
How to escape a deep drawdown in 4D Molecular Therapeutics Inc.Weekly Profit Summary & Verified Entry Point Detection - Newser
Pattern recognition hints at 4D Molecular Therapeutics Inc. upsideDollar Strength & High Return Stock Watch Alerts - Newser
Reversal indicators forming on 4D Molecular Therapeutics Inc. stockWeekly Stock Summary & Consistent Profit Trade Alerts - Newser
Transcript : 4D Molecular Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 01 - MarketScreener
Real time social sentiment graph for 4D Molecular Therapeutics Inc.2025 Trading Volume Trends & High Accuracy Swing Trade Signals - Newser
0.11%
0.12%
자본화:
|
볼륨(24시간):